Stocks · News reference

Novavax's Partners Receive Approvals For Nuvaxovid Formulation To Target SARS-CoV-2 XFG Variant

Aug 28, 2026, 12:34 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 27, 2026, 10:46 PMBenzinga News-desk
QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax
FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligibility for adults 65+ and those with high-risk conditions.
Read original at benzinga
BNTX MRNA NVAX PFE SNY
BenzingaAug 25, 2026, 3:31 PMHenry Khederian
Novavax Stock Rallies Tuesday: What's Happening?
Shares of Novavax are trading higher Tuesday morning as buying interest continues across late-stage vaccine developers.
Read original at benzinga
NVAX
BenzingaAug 20, 2026, 9:59 AMMohd Haider
Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why
Recursion, Novavax and Crispr Therapeutics slip in premarket trading after surging Wednesday on positive cancer therapy trial results.
Read original at benzinga
CRSP MRK MRNA NVAX RXRX